AI-driven drug discovery company using its Opal computational platform.
| Date | Round | Amount |
|---|---|---|
| Mar 2021 | Series B Valo Health raised a $110M extended Series B from Koch Disruptive Technologies, bringing the round to $300M, for its computational drug discovery platform. | $110M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.